Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(13)70692-3 ◽

2014 ◽

Vol 14 (4) ◽

pp. 281-290 ◽

Author(s):

Beatriz Grinsztejn ◽

Mina C Hosseinipour ◽

Heather J Ribaudo ◽

Susan Swindells ◽

Joseph Eron ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Clinical Outcomes ◽

Antiretroviral Treatment ◽

Controlled Trial ◽

Phase 3 ◽

Delayed Initiation ◽

Randomised Controlled ◽

Download Full-text

Faculty Opinions recommendation of Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718302523.793494710 ◽

2014 ◽

Author(s):

Anthony Harries

Keyword(s):

Randomised Controlled Trial ◽

Clinical Outcomes ◽

Antiretroviral Treatment ◽

Controlled Trial ◽

Phase 3 ◽

Delayed Initiation ◽

Randomised Controlled ◽

Download Full-text

Randomised-controlled trial of ketamine augmentation of ECT on neuropsychological and clinical outcomes in depression (Ketamine-ECT Study)

10.26226/morressier.5785edc9d462b80296c99817 ◽

2016 ◽

Author(s):

Ian Anderson

Keyword(s):

Randomised Controlled Trial ◽

Clinical Outcomes ◽

Controlled Trial ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Phase 3 ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Phase 3 ◽

D2 Gastrectomy ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9952956.10680055 ◽

2011 ◽

Author(s):

Jacques Bernier

Keyword(s):

Head And Neck Cancer ◽

Randomised Controlled Trial ◽

Head And Neck ◽

Neck Cancer ◽

Controlled Trial ◽

Phase 3 ◽

Conventional Radiotherapy ◽

Intensity Modulated ◽

Parotid Sparing ◽

Randomised Controlled

Download Full-text

Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

SSRN Electronic Journal ◽

10.2139/ssrn.3478102 ◽

2019 ◽

Author(s):

Chiara Cremolini ◽

Carlotta Antoniotti ◽

Daniele Rossini ◽

Sara Lonardi ◽

Fotios Loupakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Randomised Controlled Trial ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Phase 3 ◽

Open Label Phase ◽

Randomised Controlled

Download Full-text

Early Interdisciplinary Palliative Care in Patients with Previously Untreated Metastatic Oesophagogastric Cancer: A Phase 3 Randomised Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3582831 ◽

2020 ◽

Author(s):

Zhihao Lu ◽

Yu Fang ◽

Chang Liu ◽

Xiaotian Zhang ◽

Xiaowei Xin ◽

...

Keyword(s):

Palliative Care ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Phase 3 ◽

Randomised Controlled ◽

Oesophagogastric Cancer

Download Full-text

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00027-9 ◽

2021 ◽

Author(s):

Angela Lamarca ◽

Daniel H Palmer ◽

Harpreet Singh Wasan ◽

Paul J Ross ◽

Yuk Ting Ma ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Biliary Tract Cancer ◽

Controlled Trial ◽

Symptom Control ◽

Second Line ◽

Phase 3 ◽

Tract Cancer ◽

Folfox Chemotherapy ◽

Randomised Controlled

Download Full-text

Axilladissektion beim frühen Mammakarzinom mit nodalen Mikrometastasen fraglich

Deutsche Zeitschrift für Onkologie ◽

10.1055/a-1161-3531 ◽

2020 ◽

Vol 52 (02) ◽

pp. 73-76

Keyword(s):

Randomised Controlled Trial ◽

Sentinel Node ◽

Axillary Dissection ◽

Controlled Trial ◽

Phase 3 ◽

Randomised Controlled

Galimberti V et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013; 14: 297–305. doi: 10.1016/S1470- 2045(13)70035-4

Download Full-text

Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30088-8 ◽

2017 ◽

Vol 18 (3) ◽

pp. 371-383 ◽

Author(s):

Pin Zhang ◽

Tao Sun ◽

Qingyuan Zhang ◽

Zhongyu Yuan ◽

Zefei Jiang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Metastatic Breast ◽

Phase 3 ◽

Heavily Pretreated ◽

Randomised Controlled

Download Full-text